NLGIA
EXAS

Nippon Life Global Investors Americas’s Exact Sciences EXAS Stock Holding History

Nippon Life Global Investors Americas’s Portfolio EXAS Stock Details EXAS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-48,940
Closed -$4.97M – 110
2025
Q4 		$4.97M Sell
48,940
-38,570
-44% -$3.1M 0.21% 62
2025
Q3 		$4.79M Sell
87,510
-11,920
-12% -$596K 0.2% 64
2025
Q2 		$5.28M Buy
+99,430
New +$5.05M 0.23% 65

Other funds holding EXAS

VanEck Associates
VanEck Associates New York $133B AUM 72.99% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
PRS
Pinkerton Retirement Specialists Coeur D Alene, Idaho $1.16B AUM 28.78% 1-Year Est. Return
PWMAG
Pinnacle Wealth Management Advisory Group Red Bank, New Jersey $1.68B AUM 31.18% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $20.6B AUM 34.61% 1-Year Est. Return
BC
Broadwater Capital Boston, Massachusetts $138M AUM 28.86% 1-Year Est. Return

Nippon Life Global Investors Americas's EXAS Position: Q1 2026 in Review

Nippon Life Global Investors Americas sold out of Exact Sciences (EXAS) in Q1 2026, closing a stake of 48,940 shares — an estimated $4.97M sold.

Nippon Life Global Investors Americas first reported a position in EXAS in Q2 2025 and held it in 3 quarters. The position peaked at $5.28M in Q2 2025. 7 funds tracked by Wall St. Rank hold EXAS as of Q1 2026.

  • Nippon Life Global Investors Americas reported no remaining Exact Sciences position as of Q1 2026 after selling out during the quarter.
  • Nippon Life Global Investors Americas sold 48,940 Exact Sciences shares in Q1 2026, an estimated $4.97M.
  • Nippon Life Global Investors Americas first reported a position in Exact Sciences in Q2 2025 and held it in 3 quarters.
  • Nippon Life Global Investors Americas's Exact Sciences position peaked at $5.28M in Q2 2025.
  • 7 funds tracked by Wall St. Rank held Exact Sciences as of Q1 2026.

Based on Nippon Life Global Investors Americas's 13F filing for Q1 2026, filed 30 Apr 2026.